Alto Neuroscience (ANRO) Depreciation and Depletion (2024 - 2026)
Alto Neuroscience (ANRO) reported Depreciation and Depletion of $200000.0 for Q1 2026, little changed on a YoY basis from $200000.0 in Q1 2025, and up 2.04% sequentially from $196000.0 in Q4 2025.
Alto Neuroscience (ANRO) Depreciation and Depletion (2024 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 3 years of Depreciation and Depletion data on file, last reported at $200000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $200000.0; the trailing twelve-month figure through Mar 2026 stood at $796000.0 (changed N/A YoY), and the FY2025 full-year result was $700000.0, up 39.44% from the prior year.
- Depreciation and Depletion rose to $200000.0 in Q1 2026, from $196000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $202000.0 in Q4 2024 to a low of $196000.0 in Q4 2025.
- A 3-year average of $199666.7 and a median of $200000.0 in 2024 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 0.0% in 2025, while the deepest fall reached 2.97% in 2025.
- Tracing ANRO's Depreciation and Depletion over 3 years: stood at $202000.0 in 2024, then slipped by 2.97% to $196000.0 in 2025, then rose by 2.04% to $200000.0 in 2026.
- Business Quant data shows ANRO's Depreciation and Depletion at $200000.0 in Q1 2026, $196000.0 in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Alto Neuroscience | 869.36 Mn | 869.36 Mn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 196,000.00 |
| Dec 31, 2025 | 196,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 202,000.00 |
| Dec 31, 2024 | 202,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |